Arcturus receives additional support from CF Foundation to develop mRNA therapies to treat CF Aug. 5, 2019
Translate Bio reports interim data from phase I/II trial of MRT-5005 in cystic fibrosis July 31, 2019
PK and PD of GSK-2292767A, a novel low-solubility inhaled phosphoinositide 3-kinase delta inhibitor July 30, 2019
RSS